dynaCERT Provides Corporate Update

Cleantech Investing
OTC: DYFSF

All outstanding warrants of the company have been exercised funding the company treasury with $2,928,974. Funds will be used for operations for production of the HydraGen™ units. We are now planning new R&D efforts in different applications, a targeted marketing programme and focused attention on increasing sales. dynaCERT has engaged a seasoned manufacturing consultant to develop our new production facility as we continue to assemble units in our current premises. The production target in our new facility is 6,000 units per month to fulfill anticipated sales.

dynaCERT Inc. (TSXV:DYA; OTC:DYFSF) is pleased to provide a corporate update.

All outstanding warrants of the company have been exercised funding the company treasury with $2,928,974. Funds will be used for operations for production of the HydraGen™ units. We are now planning new R&D efforts in different applications, a targeted marketing programme and focused attention on increasing sales. dynaCERT has engaged a seasoned manufacturing consultant to develop our new production facility as we continue to assemble units in our current premises. The production target in our new facility is 6,000 units per month to fulfill anticipated sales.
As quoted in press release:
Jim Payne, President and CEO of dynaCERT, states,
We are thrilled with the recently announced third party validation and testing results. The HydraGen™’s capability to reach up to 40% in the reduction of greenhouse gases and over 19% in fuel savings met and exceeded our expectations. Trucks equipped with the HydraGen™ unit can reduce particulate matter by over 65%, significantly reducing the black smoke being emitted into the environment. The 550+ pages of testing results have provided the company with valuable data enabling us to further program our new Smart ECU to maximize performance for all applications.”

 
Read full press release.
Click here to connect with dynaCERT Inc. (TSXV:DYA; OTC:DYFSF) to receive an Investor Presentation.

The Conversation (0)
×